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The transcription factor nuclear factor-κB (NF-κB) is critical for the induction of inflammatory responses in 
T-cells, survival and differentiation. Antigen receptor (TCR) and co-receptor CD28 are the central regulators of 
NF-κB activation in T-cells. Progress in understanding NF-κB activation in T-cells has occurred over the years 
with the identification of individual adapters such as ADAP and GRB-2 and enzymes such as PKC-θ that 
regulate NF-κB. However, little is known whether the engagement of distinct modules by the TCR and CD28 
account for the cooperative effects of the two receptors in activating NF-κB. In this review, we discuss recent 
advances in our understanding of NF-κB regulation by TCR and CD28.  
Keywords: Adaptors; ADAP; VAV-1;GRB-2; NF-κB 
Abbreviations: NF-κB, nuclear factor-κB; IκB, inhibitors of κB; PKC-θ, protein kinase C theta; IKK, I kappa B kinase; 
CBM, Carma1-Bcl10-Malt1; IkBs, I kappa Bs; ERK, extracellular signal-regulated kinase; HPK1, hematopoietic progenitor 
kinase-1; GRB-2, growth factor receptor bound protein-2; ADAP,  adhesion and degranulation promoting adapter protein; 
PLC, phospholipase C; PKC, protein kinase C. 
To cite this article: Youg R. Thaker, Christopher E. Rudd. Distinct NF-κB activation pathways engaged by T-cell receptor 
and co-receptor CD28 on T-cells. Inflamm Cell Signal 2015; 2: e613. doi: 10.14800/ics.613. 
 
Introduction 
Nuclear factor-κB (NF-κB) includes a family of 
transcription factors that act as dimers and regulate genes 
involved in the inflammatory and immune responses, growth, 
development and differentiation. NF-κB family is comprised 
of five members: RelA (p65), RelB and c-Rel, and the 
precursor  proteins NF-κB1 (p105) and NF-κB2 (p100), 
which are processed into p50 and p52, respectively [1]. 
Activation signals from antigen receptors, inflammatory 
cytokines and infections all lead to the processing of p105 
and p100 and their dimerization with RelA component. 
Complex of NF-κB dimers bind to the κB sites on the 
promoters or enhances of various target genes leading to the 
activation or repression of a specific signaling pathway. 
Examples include the IL-2 promoter that concurrently binds 
to transcription factors NF-κB, NFAT and AP1 leading to the 
regulation of its expression during an inflammatory response 
[2]. Defects in the of NF-κB pathway is linked to the immune 
disregulation such as inflammatory disorders, autoimmune 
diseases as well as cancer [3,4]. The NF-κB pathway therefore 
is tightly regulated at multiple checkpoints, and various 
receptors including CD28 are believed to use individual 
signalling components for its regulation. In resting T cells 
NF-κB dimers remain bound to inhibitors of κB (IκB) 
molecules. Stimulation by antigen receptors and co-receptors 
induces IKK (IκB Kinase) complex activation which is 
responsible for IκB phosphorylation leading its degradation 
via ubiquitin pathway. IKK consists of three subunits, two 
catalytically active kinases IKKα, IKKβ and a 
regulatory/structural subunit, NEMO [5]. The main 
consequence of IκB degradation is the liberation of NF-κB 
dimers from cytoplasmic retention pool and subsequent 
translocation to the nucleus. However, a second phase of 
NF-κB regulation occurs in the nucleus which includes 
post-translational modifications of NF-κB subunits to fine 
tune their activity on promoters and enhancers of multiple 
genes [1,6]. These regulatory steps are common to all cell 
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types including immune cells. However, NF-κB activation in 
T-cells is orchestrated by various unique signalling receptors 
and their potential crosstalk in the regulation of NF-κB has 
been unexplored. Proximal events upstream of IKK complex 
especially role of adapters in T-cells and NF-κB activation 
will be main subject of this review briefly touching on the 
other aspects of NF-κB regulation in T-cells. 
Adapter molecules in T-cell activation 
TCR and CD28 generate digital biochemical signals which 
are amplified and converted into effector functions in a series 
of well-defined signaling pathways [7-10]. One of the earliest 
events of antigen ligation is the activation of src and syk 
family kinases such as Lck and ZAP-70 respectively, 
phosphorylating various enzymes and adapter proteins. 
Adapters are a unique group of proteins that have well 
defined structural domains but lack enzymatic activity [9,11]. 
Instead, they function as scaffolds bringing other proteins 
into the proximity of each other, nucleating and bridging 
multi-molecular signaling complexes [8,12]. Adapters can also 
induce conformational changes in their binding partners, 
potentially capable of regulating their activity and function 
[11,12]. Adapter scaffolds can regulate T-cell function in a 
positive or negative manner dependent upon the signaling 
complex and pathway. The importance of adapters in 
immune cell function and development has been underscored 
by in vivo and cell-line approaches, leading to important 
insights of their role in the transmission and integration of 
early signaling events generated by antigen receptor (TCR) 
Figure 1. NF-kB activation in T-cells: a) upon engagement of the antigen receptor (TCR) by peptide-MHC, proximal signaling events 
activate tyrosine kinase, zeta-chain-associated protein kinase 70 (ZAP-70). ZAP-70 phosphorylates SLP-76 and LAT thereby recruiting 
several proteins resulting in the formation of a signalosome complex responsible for the activation of several downstream targets including 
protein kinase C theta (PKC-θ). PCK-θ is essential intermediate that couples TCR signals to NF-kB via its association with I kappa B kinase 
(IKK) and activation of Carma1-Bcl10-Malt1 (CBM) complex. IKK complex phosphorylates I kappa Bs (IkBs), leading to their 
polyubiquitination, release of NF-kB dimers and their translocation into the nucleus. ADAP is a scaffold protein that regulates CBM complex 
assembly upon TCR ligation and is required for TCR mediated NF-kB signaling but not CD28 pathway [23,25]. CD28 co-stimulation 
dependent NF-kB activation, on the other hand, is dependent on the binding of GRB-2 to its cytoplasmic tail. b) GRB-2 binds to the YMNF 
motif in the cytoplasmic tail of CD28, and a point mutation (N-Q) that selectively disrupts this binding, abrogates CD28 driven NF-kB 
activation. VAV1 is required for CD28 NF-kB activation likely via its association with IKKα and GRB-2[23,39]. CD28 engagement also 
facilitates activation of PDK1 and its binding to the PKC-θ to activate NF-kB via classical pathway. CD28 ligation has been shown to 
activate alternate-like NF-kB pathway by recruiting p52/RelA dimers in a Vav1 dependent pathway, however, precise mechanism remains 
unclear [45]. In this situation, NIK, which is required for the alternate pathway is likely to be activated via PI3K-PDK1-AKT1 pathway upon 
CD28 engagement. PKC-θ also associates with CD28 in the immunological synapse via Lck, and regulates its localization and downstream 
signaling [46]. 
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to downstream effector functions. Several adapter for these 
functions are exclusively expressed in the hematopoietic 
cells, while others are more widely expressed[12]. 
Characterization of key positive adapters in T-cells has 
helped in our understanding of T-cell activation mechanisms 
and regulation. Key positive adapters include: 
SH2-DOMAIN CONTAINING LEUKOCYTE-SPECIFIC 
PHOSPHOPROTEIN (SLP-76), mice null for SLP-76 have 
severe disruption in thymic T-cell development and IL-2 
production [13-15]; LINKER FOR T-CELL ACTIVATION 
(LAT) is a transmembrane adapter with multiple cytoplasmic 
tyrosine phosphorylation/binding sites, an important 
signaling node to nucleate multi-protein complex of GADS, 
SLP-76, PLC-gamma, ITK and GRB-2. LAT or SLP-76 null 
mice displayed similar phenotype and a complete block in 
thymopoiesis at the pro-T3 stage [16]. In addition to this, 
Jurkat T-cell mutant lines lacking either SLP-76 or LAT 
expression showed a vital requirement of both molecules in 
mediating TCR-induced PLCγ1 phosphorylation, 
extracellular signal-regulated kinase (ERK) activation, Ca2+ 
influx and IL-2 promoter activity [13,17,18]; GRB-2 RELATED 
ADAPTER DOWNSTREAM OF SHC (GADS) is a SH2- 
and SH3-domain-containing adaptor protein and plays 
crucial role in TCR-mediated signalling by linking LAT with 
SLP-76 adapter, thereby coupling membrane-proximal 
events to downstream signaling pathways. GADS-null mice 
revealed impaired T-cell development, with specific defects 
in both positive and negative selection of thymocytes [19]. 
GADS also associates with the serine/threonine kinase 
hematopoietic progenitor kinase-1 (HPK1) which has been 
implicated in the activation of the JNK pathway [20]. Adapters 
such as ADAP and SKAP1 with critical roles in the 
regulation of T-cell adhesion, viral transmission, NF-κB 
regulation is described in detail elsewhere [10,23,24,25]. 
Negative regulators of T-cell activation include 
PHOSPHOPROTEIN ASSOCIATED WITH GEMS (PAG), 
a transmembrane adapter protein that binds Csk (c-terminal 
Src kinase) which phosphorylates and inactivates src kinases 
(e.g. Lck) in resting cells [21]. Other adapters that negatively 
regulate T-cell function is SH2-INTERACTING 
TRANSMEMBRANE ADAPTOR PROTEIN (SIT) by 
binding to Csk and protein tyrosine phosphatase 2 (SHP-2) 
enzymes [22].  
Role of adapters in NF-κB activation 
Generation of knock-out mice deficient for individual 
signalling proteins, together with biochemical functional 
studies, have identified several adapter proteins required for 
the co-stimulation induced NF-κB activation[26]. These initial 
reports also showed that co-stimulation induced NF-κB 
activation was dependent on the initial tyrosine 
phosphorylation cascade that engages adapters in 
multiprotein complexes containing several proteins required 
for NF-κB activation such as Src homology 2 
domain-containing leukocyte phosphoprotein 76 (SLP-76), 
growth factor receptor bound protein-2 (GRB-2), GRB-2 
related adapter downstream of Shc (GADS), adhesion and 
degranulation promoting adapter protein (ADAP) and 
proteins with enzymatic activity as well as adapter-like 
functions, such as phospholipase C (PLC) γ and the exchange 
factor Vav1 [27]. While Vav1 contributes to Rac-dependent 
reorganization of the actin cytoskeleton, activated PLCγ1 
activates protein kinase C (PKC) to generate diacylglycerol 
(DAG) and IP3. Adapter SLP-76 has no intrinsic enzymatic 
activity but its expression is required for the activation of 
NF-κB as shown in Jurkat cells J14 deficient in SLP-76 [28]. 
A role for SLP-76 in vivo has been less certain given that 
there are fewer mature T-cells in the periphery due to a 
severe block in thymic development at double negative (DN) 
stage [14,15]. Disruption in the thymic T-cell development as a 
consequence of defective NF-κB could not be ruled out. 
GRB-2 on the other hand has been demonstrated to directly 
associate with CD28 cytoplasmic tail [29,30], and its role in the 
activation of NF-κB pathway has been examined previously 
in Jurkat cells [31], showing its expression is required for the 
CD28 linked NF-κB pathway. In our recent study, we 
demonstrated that GRB-2 is an essential component of CD28 
pathway and is vital for achieving full NF-κB activation 
while intriguingly, it did not participate directly in the TCR 
driven pathway [23]. Another study claimed a role for GADS 
in this pathway [32], however, we have consistently observed 
stronger association of GRB-2 but not GADS with CD28 [23]. 
The point of CD28/TCR convergence of NF-κB activation 
remains unknown.  
CD28 and NF-κB activation 
Signals from co-receptors, particularly CD28 appear to 
cooperate with primary TCR signaling for optimal T-cell 
activation [33]. NF-κB pathway is no exception, and CD28 is 
a crucial component to achieve full immune response as 
demonstrated by CD28 KO cells that have diminished IL-2 
production and activation. However, despite the importance 
of CD28 in potentiating TCR activation of T-cells (i.e. 
co-stimulation), increasing evidence has shown that its 
ligation alone can induce signaling events in T-cells [34,35]. 
This is further supported by studies on the use of mitogenic 
CD28 antibody which can induce proliferation and cytokine 
burst in the absence of TCR ligation [36]. We previously 
showed that GEF VAV1 binding to CD28 involves the 
intermediate binding of another adaptor GRB-2 [29,30]. Other 
investigators have shown that the loss of either GRB-2 or 
GADS binding to CD28 can abrogate NK-κB activation in 
Jurkat T-cells [37]. In addition, Tuosto et al. have reported 
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that non-mitogenic anti-CD28 can deliver a unique signal 
leading to the recruitment of p52/Rel-A complexes on 
Bcl-xL promoter [38]. They showed that CD28 can co-operate 
with VAV-1 to activate NF-κB in a pathway involving Rac-1 
and mitogen-activated kinase kinase 1 [35,39]. 
On the other hand, Ca2+-independent PKC subfamily 
member PKC-θ predominantly expressed in T-cells has 
important and non-redundant roles in T-cell activation 
particularly via regulation of NF-κB [40,41]. The activity of 
PKC-θ is essentially regulated by its membrane localization 
and conformational changes [42]. Recently, a conserved 
proline-rich motif in the V3 domain of PKC-θ was found to 
be required for association with CD28 and its immunological 
synapse localization and downstream effector functions [43]. 
Thus, CD28 directly engages proximal pathways leading to 
the NF-κB activation in T-cells. 
New insights into the regulation of NF-κB by CD28 and 
TCR 
Despite the progress made in understanding NF-κB 
regulation in T-cells, studies dissecting the individual 
components of TCR and CD28-mediated NF-κB activation 
in primary T-cells have been lacking. In our recent paper, we 
addressed this issue by using primary T-cells from various 
knock-out (Cd28−/−, adap−/−) and knock-in (i.e. Cd28 Y-170F) 
mice in conjunction with transfected Jurkat T-cells and 
showed that the TCR and CD28 use distinct pathways for the 
activation of the NF-κB pathway in T-cells [23]. CD28 
engaged GRB-2 via YMNM motif in its cytoplasmic tail, 
which was required for NF-κB induction. Using Y170F 
knock-in mice, NF-κB activation was significantly dampened, 
so was the case when endogenous GRB-2 was depleted. 
CD28 induced NF-κB pathway was further delineated by 
showing Vav1 as an important component of CD28/GRB-2 
pathway. Vav1 expression significantly up-regulated NF-κB, 
and its depletion abrogated NF-κB activation in response to 
CD28 engagement. Surprisingly, CD28 KO primary T-cells 
had normal NF-κB response when engaged by anti-TCR 
antibodies. Further, CD28 activated NF-κB pathway was 
fully functional in ADAP deficient primary cells but 
defective TCR pathway. In both cases (ADAP or CD28 
deficient primary cells), synergy in NF-κB co-ligation of 
CD3 and CD28 was lost. The independent nature of CD3 and 
CD28 pathways in NF-κB activation was also supported by 
results from LAT deficient cells showing normal CD28 
activation, but no activation via TCR/CD3 pathway. Our 
findings provide evidence that the CD28 and TCR pathways 
regulate NF-κB activity via different signaling modules of 
GRB-2/VAV1 and LAT/ADAP respectively. 
Concluding remarks 
In lymphocytes, NF-κB controls expression of diverse set 
of genes involved in the productive immune response, 
division and growth. NF-κB has been topic of intense study 
for several decades, and recent years have witness, complex 
interplay of signaling pathways that shape the spatial and 
timely outcome of NF-κB activation [44]. To successfully 
interfere NF-κB pathway in clinical settings, receptors as 
well as co-receptor (stimulatory/inhibitory) engaging NF-κB 
pathway entail further understanding. In this direction, we 
have uncovered that CD28 and CD3 use unique signaling 
modules of GRB-2/Vav1 and LAT/ADAP to achieve full 
activation of NF-κB in T-cells respectively.  
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